Healthcare -
Medical - Devices - NYSE - US
$ 265.16
-0.177 %
$ 7.43 B
Market Cap
-4.06
P/E
Price Target
Average
50.85%
Revenue Forecast
Estimate
4.67%
EBIT
Estimate
--11.47%
Net Income
Estimate
30.79%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Bio-Rad Laboratories, Inc.
Wall Street analysts predict an average 1-year price target for BIO of $400 , with forecasts ranging from
a
low of
$400 to a high of $400 .
BIO Lowest Price Target
Wall Street Target
400 USD
50.85%
BIO Average Price Target
Wall Street Target
400 USD
50.85%
BIO Highest Price Target
Wall Street Target
400 USD
50.85%
REVENUE FORECAST
Revenue Forecast Chart BIO
EBIT FORECAST
EBIT Forecast Chart BIO
NET INCOME FORECAST
Net Income Chart BIO